Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Application of Nelarabine for Refractory or Relapsed T-Lymphatic Neoplasms In Adults Before Allogeneic Stem Cell Transplantation.

Evgeny Klyuchnikov, MD, Nicolaus Kröger, MD, Francis Ayuketang, MD, Claudia Langebrake, MD, Christine Wolschke, MD, Heinrich Lellek, MD, Axel R. Zander, PhD, Ulrike Bacher, MD

Blood (2010) 116 (21): 3496.

https://doi.org/10.1182/blood.V116.21.3496.3496

Published: 2010

Journal Articles

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Thomas StÜbig, York Hildebrand, Karla Jungk, Aga Konielsk, Lars Lange, Thomas Binder, Heidi Duske, Djordje Atanackovic, Boris Fehse, Thomas Eiermann, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 5178.

https://doi.org/10.1182/blood.V116.21.5178.5178

Published: 2010

Journal Articles

Disease-Specific Recovery of Regulatory T Cell After Allogenic Stem Cell Transplantation

Thomas St\)big, Michael Lioznov, Ulrike Fritsche-Friedland, Haefaa Alchalby, Christine Wolschke, MD, Francis Ayuketang Ayuk, Ulrike Bacher, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 4689.

https://doi.org/10.1182/blood.V116.21.4689.4689

Published: 2010

Journal Articles

Dose Finding Study of Lenalidomide as Maintenance Therapy In Multiple Myeloma After Allogeneic Stem Cell Transplantation

Christine Wolschke, Stefan O Schonland, Ute Hegenbart, Thomas Stübig, Marion Heinzelmann, York Hildebrandt, Michael Lioznov, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 2376.

https://doi.org/10.1182/blood.V116.21.2376.2376

Published: 2010

Journal Articles

Related Vs Unrelated Donors After Auto-Allo Tandem Stem Cell Transplantation for Newly Diagnosed Patients with Multiple Myeloma.

Nicolaus Kröger, MD, Tatjana Zabelina, Marion Heinzelmann, Georgia Schilling, Christine Wolschke, Heinrich Lellek, Thomas Stübig, Maite Lestin, Haefaa Alchalby, Francis Ayuk, Djordje Atanackovic, M.D., Ulrike Bacher, Boris Fehse, Axel R. Zander

Blood (2009) 114 (22): 1201.

https://doi.org/10.1182/blood.V114.22.1201.1201

Published: 2009

Journal Articles

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kröger, MD, Avichai Shimoni, Georgia Schilling, Rainer Schwerdtfeger, MD, Martin Bornhäuser, Arnon Nagler, Axel R. Zander, Marion Heinzelmann, Ronald Brand, Goesta Gahrton, MD, PhD, Currly Morris, Dietger Niederwieser, T. M. de Witte

Blood (2009) 114 (22): 2308.

https://doi.org/10.1182/blood.V114.22.2308.2308

Published: 2009

Journal Articles

Induction Chemotherapy Followed Immediately by Busulfan-Based Reduced Conditioning and Allografting in Elderly Patients with Advanced MDS or sAML.

Nicolaus Kröger, MD, Tatjana Zabelina, Christine Wolschke, Heinrich Lellek, Thomas Stübig, Maite Lestin, Haefaa Alchalby, Francis Ayuk, Ulrike Bacher, Boris Fehse, Axel R. Zander

Blood (2009) 114 (22): 3387.

https://doi.org/10.1182/blood.V114.22.3387.3387

Published: 2009

Journal Articles

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen.

Francis Ayuk, MD, Tatjana Zabelina, MD, Ulrike Bacher, MD, Christine Wolschke, MD, Heinrich Lellek, MD, Thomas Eiermann, MD, Rudolf Erttmann, MD, Nicolaus Kröger, MD, Axel R. Zander, MD

Blood (2009) 114 (22): 3393.

https://doi.org/10.1182/blood.V114.22.3393.3393

Published: 2009

Journal Articles

Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute Lymphoblastic Leukemia (ALL) Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Complete Remission: Results From the GMALL Study Group.

Matthias Stelljes, MD, Mareike David, Renate Arnold, MD, Dietrich W Beelen, MD, Wolfgang A Bethge, MD, Martin Bornhäuser, MD, Jolanta Dengler, MD, Juergen Finke, MD, Hans J Kolb, MD, Karin Kolbe, MD, Nicolaus Kröger, MD, Dietger Niederwieser, MD, Wolf Rösler, MD, Rainer Schwerdtfeger, MD, Joachim Kienast, MD, Nicola Goekbuget, MD, Dieter Hoelzer, MD, PhD

Blood (2009) 114 (22): 3352.

https://doi.org/10.1182/blood.V114.22.3352.3352

Published: 2009

Journal Articles

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

Blood (2009) 114 (22): 324.

https://doi.org/10.1182/blood.V114.22.324.324

Published: 2009

Journal Articles

A Characteristic Cytokine/Chemokine Milieu Is Present in the Bone Marrow Environment of Multiple Myeloma Patients Before and After Allogeneic Stem Cell Transplantation.

Yanran Cao, MD, Tim Luetkens, MD, Sebastian Kobold, MD, York Hildebrandt, Maja Gordic, Nesrine Lajmi, Sabrina Meyer, Katrin Bartels, Axel R. Zander, MD, Carsten Bokemeyer, MD, Nicolaus Kröger, MD, Djordje Atanckovic, MD

Blood (2009) 114 (22): 2795.

https://doi.org/10.1182/blood.V114.22.2795.2795

Published: 2009

Journal Articles

Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Michel Van Gelder, MD, PhD, Johannes Schetelig, Liisa Volin, Johan Maertens, Gerard Socié, Eefke Petersen, MD, Henrike Thomssen, MD, Anja Biezen, Ronald Brand, T. M. de Witte, Nicolaus Kröger, MD

Blood (2009) 114 (22): 293.

https://doi.org/10.1182/blood.V114.22.293.293

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Blood (2009) 114 (22): 51.

https://doi.org/10.1182/blood.V114.22.51.51

Published: 2009

Journal Articles

Impact of Cytogenetics on Outcome of Patients with MDS or Secondary AML Undergoing Allogeneic HSCT from HLA-Identical Siblings: A Retrospective Analysis of the EBMT-CLWP.

Francesco Onida, MD, Ronald Brand, PhD, Anja van Biezen, Renee M. Barge, MD, Leo F. Verdonck, MD, Jurgen Finke, MD, Dietrich Beelen, MD, Rodrigo Martino, MD, José M. Fernandez-Ranada, MD, Dietger Niederwieser, MD, Nicolaus Kröger, MD, Theo de Witte, MD

Blood (2006) 108 (11): 2653.

https://doi.org/10.1182/blood.V108.11.2653.2653

Published: 2006

Journal Articles

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Eray Goekkurt, MD, Jan Stoehlmacher, MD, Christian Stueber, Christine Wolschke, MD, Tatjana Zabelina, MD, Thomas Eiermann, MD, Thomas Binder, MD, Simona Iacobelli, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2005) 106 (11): 2730.

https://doi.org/10.1182/blood.V106.11.2730.2730

Published: 2005

Journal Articles

Serum Free Light Chain [FLC] Assay in Multiple Myeloma Patients Who Achieved Negative Immunofixation after Allogeneic Stem Cell Transplantation.

Ulrike Moesbauer, Heike Schieder, MD, Helmut Renges, MD, Francis Ayuk, MD, Axel Zander, MD, Nicolaus Kröger, MD

Blood (2005) 106 (11): 2023.

https://doi.org/10.1182/blood.V106.11.2023.2023

Published: 2005

Journal Articles

Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.

Avichai Shimoni, MD, Nicolaus Kröger, MD, Tatjana Zabelina, MD, Frances Ayuk, MD, Izhar Hardan, MD, Moshe Yeshurun, MD, Noga Shem-Tov, MD, Abraham Avigdor, MD, Isacc Ben-Bassat, MD, Axel Zander, MD, Arnon Nagler, MD

Blood (2004) 104 (11): 2750.

https://doi.org/10.1182/blood.V104.11.2750.2750

Published: 2004

Journal Articles

Early In Vivo Depletion of Suicide Gene-Modified T-Lymphocytes Transplanted in Conjunction with CD34 + Enriched Blood Stem Cells May Be Associated with an Increased Risk of Secondary Graft Failure.

Boris Fehse, PhD, Francis A. Ayuk, MD, Nicolaus Kröger, MD, Lubin Fang, MD, Klaus Kühlcke, PhD, Marion Heinzelmann, Tatjana Zabelina, MD, Axel A. Fauser, MD, PhD, Axel R. Zander, MD

Blood (2004) 104 (11): 1742.

https://doi.org/10.1182/blood.V104.11.1742.1742

Published: 2004

NARROW

Application of Nelarabine for Refractory or Relapsed T-Lymphatic Neoplasms In Adults Before Allogeneic Stem Cell Transplantation.

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Disease-Specific Recovery of Regulatory T Cell After Allogenic Stem Cell Transplantation

Dose Finding Study of Lenalidomide as Maintenance Therapy In Multiple Myeloma After Allogeneic Stem Cell Transplantation

Related Vs Unrelated Donors After Auto-Allo Tandem Stem Cell Transplantation for Newly Diagnosed Patients with Multiple Myeloma.

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Induction Chemotherapy Followed Immediately by Busulfan-Based Reduced Conditioning and Allografting in Elderly Patients with Advanced MDS or sAML.

Outcome of HLA-Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation Depends On the Intensity of the Conditioning Regimen.

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

A Characteristic Cytokine/Chemokine Milieu Is Present in the Bone Marrow Environment of Multiple Myeloma Patients Before and After Allogeneic Stem Cell Transplantation.

Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Allogeneic Stem Cell Transplant Versus Tandem High-Dose Melphalan for Front-Line Treatment of Deletion 13q14 Myeloma – An Interim Analysis of the German DSMM V Trial.

Impact of Cytogenetics on Outcome of Patients with MDS or Secondary AML Undergoing Allogeneic HSCT from HLA-Identical Siblings: A Retrospective Analysis of the EBMT-CLWP.

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Serum Free Light Chain [FLC] Assay in Multiple Myeloma Patients Who Achieved Negative Immunofixation after Allogeneic Stem Cell Transplantation.

Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.

Early In Vivo Depletion of Suicide Gene-Modified T-Lymphocytes Transplanted in Conjunction with CD34 + Enriched Blood Stem Cells May Be Associated with an Increased Risk of Secondary Graft Failure.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only